[HTML] frontiersin.org

[HTML][HTML] Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: a systematic review

VM Kroesen, MI Gröschel, N Martinson… - Frontiers in …, 2017 - frontiersin.org
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional
tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies …
被引用次数：83 相关文章

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review

VM Kroesen, MI Groschel, N Martinson… - Frontiers in …, 2017 - discovery.ucl.ac.uk
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional
tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies …
[PDF] academia.edu

[PDF][PDF] Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review

VM Kroesen, MI Gröschel, N Martinson… - Frontiers in …, 2017 - academia.edu
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional
tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies …
[PDF] scienceopen.com

[PDF][PDF] Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review

VM Kroesen, MI Gröschel, N Martinson… - Frontiers in …, 2017 - scienceopen.com
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional
tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies …

Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: A systematic review

VM Kroesen, MI Gröschel, N Martinson… - Frontiers in …, 2017 - portalrecerca.uab.cat
Abstract© 2017 Kroesen, Gröschel, Martinson, Zumla, Maeurer, van der Werf and Vilaplana.
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional …

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review.

VM Kroesen, MI Gröschel, N Martinson… - Frontiers in …, 2017 - europepmc.org
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional
tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies …
[HTML] nih.gov

[HTML][HTML] Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review

VM Kroesen, MI Gröschel, N Martinson… - Frontiers in …, 2017 - ncbi.nlm.nih.gov
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional
tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies …
[PDF] researchgate.net

[PDF][PDF] Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review

VM Kroesen, MI Gröschel, N Martinson… - Frontiers in …, 2017 - researchgate.net
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional
tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies …

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review

VM Kroesen, MI Gröschel, N Martinson… - Frontiers in …, 2017 - pubmed.ncbi.nlm.nih.gov
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional
tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies …

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review

VM Kroesen, MI Gröschel, N Martinson… - Frontiers in …, 2017 - research.rug.nl
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional
tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies …